0
     

Report Added
Report already added
Vascular Patches Market by Material (Biologic, Synthetic), Application (Open Repair of Abdominal Aortic Aneurysm, Congenital Heart Disease, Carotid Endarterectomy), End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2027

Vascular Patches Market by Material (Biologic, Synthetic), Application (Open Repair of Abdominal Aortic Aneurysm, Congenital Heart Disease, Carotid Endarterectomy), End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2027

The global vascular patches market is valued at an estimated USD 353 million in 2022 and is projected to reach USD 517 million by 2027, at a CAGR of 7.9% during the forecast period. Market growth is driven by factors such as the rising incidence of CVD, the rise in the volume of surgical procedures, coupled with the increasing adoption of biological patches for vascular surgeries.

“The biologic vascular patches held the largest share of the vascular patches market, by material”

Based on material, the global vascular patches market is segmented into biological and synthetic vascular patches. Biologic vascular patches held a significant share in the market. It is also the fastest-growing material segment in this market. Growth in this segment is primarily driven by the advantages offered by the biologic patches over their synthetic counterparts.

“The vascular bypass surgery segment is the fastest growing segment of the vascular patches market, by application”

Based on application, the vascular patches market is segmented into carotid endarterectomy (CEA), open repair of abdominal aortic aneurysm (AAA), congenital heart diseases, vascular bypass surgery, and other applications. The vascular bypass surgery is expected to witness the fastest growth during the forecast period. The high growth rate of vascular bypass surgery can be attributed to the availability of reimbursement in emerging and developed economies.

“Among the end users, the hospitals segment is anticipated to register the highest growth during the forecast period”

Based on end users, the vascular patches market is segmented into hospitals and ambulatory surgical centers. The hospitals segment is anticipated to witness growth at the highest rate during the forecast period. The growth can be attributed to the increasing number of hospitals offering better healthcare services and infrastructure.

“The Asia Pacific market is expected to grow at the highest CAGR during the forecast period”

The global vascular patches market is segmented into four regions - North America, Europe, the Asia Pacific, and Rest of the World. The Asia Pacific region is expected to witness the highest growth in the vascular patches market during the forecast period. The high growth in this region can primarily be attributed to the large number of target population, and improved healthcare infrastructures in Southeast Asian countries.

The primary interviews conducted for this report can be categorized as follows:
•By Company Type: Tier 1 - 30%, Tier 2 - 45%, and Tier 3 - 25%
•By Designation: C-level - 28%, D-level - 32%, and Others - 40%
•By Region: North America - 35%, Europe - 21%, Asia Pacific - 28%, Rest of the World – 16%

Lists of Companies Profiled in the Report:
•Baxter International, Inc. (US)
•LeMaitre Vascular, Inc. (US)
•W. L. Gore & Associates, Inc. (US)
•Getinge AB (Sweden)
•B Braun (Germany)
•Artivion, Inc (US)
•Edwards Lifesciences Corporation (US)
•Aziyo Biologics, Inc. (US)
•Terumo Corporation (Japan)
•BD (US)
•Labcor Laboratórios Ltda. (Brazil)
•VUP Medical (Czech Republic)
•Aegis Lifesciences (India)
•SynkroMax Biotech Pvt. Ltd. (India)

Research Coverage:
This report provides a detailed picture of the global vascular patches market. It aims at estimating the size and future growth potential of the market across different segments, such as material, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall vascular patches market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
Table of Contents

1INTRODUCTION19
1.1STUDY OBJECTIVES19
1.2MARKET DEFINITION19
1.2.1INCLUSIONS & EXCLUSIONS20
1.3MARKET SCOPE20
FIGURE 1VASCULAR PATCHES MARKET20
1.3.1YEARS CONSIDERED21
1.4CURRENCY CONSIDERED21
1.5STAKEHOLDERS21
1.6SUMMARY OF CHANGES21
1.7LIMITATIONS22
2RESEARCH METHODOLOGY23
2.1RESEARCH DATA23
FIGURE 2RESEARCH DESIGN23
2.1.1SECONDARY SOURCES23
2.1.1.1Secondary sources25
2.1.2PRIMARY DATA25
2.1.2.1Key data from primary sources26
2.1.2.2Key industry insights27
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS27
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION28
2.2MARKET SIZE ESTIMATION28
2.2.1BOTTOM-UP APPROACH29
FIGURE 5MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH29
FIGURE 6MARKET SIZE ESTIMATION: TOP-DOWN APPROACH30
FIGURE 7CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS30
2.3MARKET BREAKDOWN AND DATA TRIANGULATION31
FIGURE 8DATA TRIANGULATION METHODOLOGY31
2.4MARKET SHARE ANALYSIS32
2.5STUDY ASSUMPTIONS32
2.6RISK ASSESSMENT32
TABLE 1RISK ASSESSMENT: VASCULAR PATCHES MARKET32
2.7LIMITATIONS33
2.7.1METHODOLOGY-RELATED LIMITATIONS33
2.7.2SCOPE-RELATED LIMITATIONS33
2.8GROWTH RATE ASSUMPTIONS33
3EXECUTIVE SUMMARY34
FIGURE 9VASCULAR PATCHES MARKET, BY MATERIAL, 2022 VS. 2027 (USD MILLION)34
FIGURE 10VASCULAR PATCHES MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)35
FIGURE 11VASCULAR PATCHES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)35
FIGURE 12GEOGRAPHICAL SNAPSHOT OF VASCULAR PATCHES MARKET36
4PREMIUM INSIGHTS37
4.1VASCULAR PATCHES MARKET OVERVIEW37
FIGURE 13RISING PREVALENCE OF CVD AND GROWING VOLUME OF CARDIOVASCULAR SURGERIES TO DRIVE MARKET37
4.2ASIA PACIFIC: VASCULAR PATCHES MARKET, BY MATERIAL (2021)38
FIGURE 14BIOLOGICAL VASCULAR PATCHES ACCOUNTED FOR LARGEST SHARE IN 202138
4.3VASCULAR PATCHES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES39
FIGURE 15CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD39
4.4VASCULAR PATCHES MARKET: GEOGRAPHIC MIX39
FIGURE 16ASIA PACIFIC MARKET TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD39
4.5VASCULAR PATCHES MARKET: DEVELOPED VS. EMERGING ECONOMIES40
FIGURE 17EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD40
5MARKET OVERVIEW41
5.1INTRODUCTION41
5.2MARKET DYNAMICS41
FIGURE 18VASCULAR PATCHES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES41
5.2.1DRIVERS42
5.2.1.1Rising incidence of CVD42
5.2.1.2Growing geriatric population and subsequent prevalence of vascular diseases42
5.2.1.3Rising number of cardiovascular surgeries worldwide43
5.2.1.4Availability of reimbursement for vascular procedures43
5.2.1.5Growing adoption of biological patches44
5.2.2RESTRAINTS44
5.2.2.1High procedural cost of vascular surgeries and associated products44
5.2.2.2Product failures and recalls44
5.2.3OPPORTUNITIES45
5.2.3.1Emerging economies45
5.2.3.2Growth in the number of hospitals & surgical centers45
5.2.4CHALLENGES46
5.2.4.1Lack of skilled professionals46
5.3REGULATORY LANDSCAPE46
TABLE 2NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS46
TABLE 3ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS47
TABLE 4LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS47
TABLE 5REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS47
5.3.1NORTH AMERICA48
5.3.1.1US48
5.3.1.2Canada48
5.3.2EUROPE48
5.3.3ASIA PACIFIC48
5.3.3.1China48
5.3.3.2Japan48
5.3.3.3India48
5.3.4LATIN AMERICA49
5.3.4.1Brazil49
5.3.4.2Mexico49
5.3.5MIDDLE EAST49
5.3.6AFRICA50
5.4PORTER’S FIVE FORCES ANALYSIS50
TABLE 6VASCULAR PATCHES MARKET: PORTER’S FIVE FORCES ANALYSIS50
5.4.1THREAT FROM NEW ENTRANTS50
5.4.2THREAT FROM SUBSTITUTES50
5.4.3BARGAINING POWER OF BUYERS50
5.4.4BARGAINING POWER OF SUPPLIERS51
5.4.5DEGREE OF COMPETITION51
5.5TECHNOLOGY ANALYSIS51
5.6VALUE CHAIN ANALYSIS51
5.7SUPPLY CHAIN ANALYSIS52
FIGURE 19VASCULAR PATCHES MARKET: SUPPLY CHAIN ANALYSIS53
5.8ECOSYSTEM ANALYSIS53
FIGURE 20VASCULAR PATCHES MARKET: ECOSYSTEM ANALYSIS54
5.8.1ECOSYSTEM ROLE54
6VASCULAR PATCHES MARKET, BY MATERIAL55
6.1INTRODUCTION56
TABLE 7VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)56
6.2BIOLOGIC VASCULAR PATCHES56
6.2.1WIDE USAGE IN ARTERIAL CLOSURE DURING CARDIAC SURGERIES TO DRIVE MARKET56
TABLE 8BIOLOGIC VASCULAR PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION)57
6.3SYNTHETIC VASCULAR PATCHES57
6.3.1HIGH RISK OF INFECTION DESPITE BEING COST-EFFICIENT TO RESTRAIN MARKET57
TABLE 9SYNTHETIC VASCULAR PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION)57
7VASCULAR PATCHES MARKET, BY APPLICATION58
7.1INTRODUCTION59
TABLE 10VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)59
7.2CAROTID ENDARTERECTOMY59
7.2.1INCREASING PATCH ANGIOPLASTY PROCEDURES TO DRIVE MARKET59
TABLE 11VASCULAR PATCHES MARKET FOR CAROTID ENDARTERECTOMY, BY REGION, 2020–2027 (USD MILLION)60
7.3VASCULAR BYPASS SURGERY60
7.3.1RISING PREVALENCE OF VASCULAR DISEASES TO DRIVE MARKET60
TABLE 12VASCULAR PATCHES MARKET FOR VASCULAR BYPASS SURGERY, BY REGION, 2020–2027 (USD MILLION)60
7.4CONGENITAL HEART DISEASE61
7.4.1USE OF SYNTHETIC & BIOLOGIC VASCULAR PATCHES FOR CORRECTIVE SURGERIES TO DRIVE MARKET61
TABLE 13VASCULAR PATCHES MARKET FOR CONGENITAL HEART DISEASE, BY REGION, 2020–2027 (USD MILLION)61
7.5OPEN REPAIR OF ABDOMINAL AORTIC ANEURYSM61
7.5.1RISING INCIDENCE OF AAA TO DRIVE DEMAND FOR VASCULAR PATCHES61
TABLE 14VASCULAR PATCHES MARKET FOR OPEN REPAIR OF ABDOMINAL AORTIC ANEURYSM, BY REGION, 2020–2027 (USD MILLION)62
7.6OTHER APPLICATIONS62
TABLE 15VASCULAR PATCHES MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)63
8VASCULAR PATCHES MARKET, BY END USER64
8.1INTRODUCTION65
TABLE 16VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)65
8.2HOSPITALS65
8.2.1RISING BURDEN OF CVD AND DEVELOPING INFRASTRUCTURE IN EMERGING ECONOMIES TO DRIVE MARKET65
TABLE 17VASCULAR PATCHES MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)66
8.3AMBULATORY SURGICAL CENTERS66
8.3.1RISING NUMBER OF ASCS TO PROPEL MARKET GROWTH66
TABLE 18VASCULAR PATCHES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2027 (USD MILLION)66
9VASCULAR PATCHES MARKET, BY REGION67
9.1INTRODUCTION68
TABLE 19VASCULAR PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION)68
9.2NORTH AMERICA68
FIGURE 21NORTH AMERICA: VASCULAR PATCHES MARKET SNAPSHOT69
TABLE 20NORTH AMERICA: VASCULAR PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)69
TABLE 21NORTH AMERICA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)70
TABLE 22NORTH AMERICA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)70
TABLE 23NORTH AMERICA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)70
9.2.1US71
9.2.1.1Favorable government reimbursements for vascular surgeries to drive market71
TABLE 24US: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)71
TABLE 25US: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)71
TABLE 26US: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)72
9.2.2CANADA72
9.2.2.1High incidence of vascular diseases to support market growth72
TABLE 27CANADA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)72
TABLE 28CANADA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)73
TABLE 29CANADA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)73
9.3EUROPE73
TABLE 30EUROPE: VASCULAR PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)74
TABLE 31EUROPE: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)74
TABLE 32EUROPE: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)74
TABLE 33EUROPE: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)75
9.3.1GERMANY75
9.3.1.1Presence of a large target patient population to support market growth75
TABLE 34GERMANY: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)75
TABLE 35GERMANY: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)76
TABLE 36GERMANY: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)76
9.3.2FRANCE76
9.3.2.1High prevalence of CVD to drive demand for vascular patches76
TABLE 37FRANCE: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)77
TABLE 38FRANCE: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)77
TABLE 39FRANCE: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)77
9.3.3UK78
9.3.3.1Rising geriatric population and subsequent prevalence of CHD to drive market78
TABLE 40UK: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)78
TABLE 41UK: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)79
TABLE 42UK: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)79
9.3.4ITALY79
9.3.4.1Increasing incidence of CHD to support market growth79
TABLE 43ITALY: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)80
TABLE 44ITALY: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)80
TABLE 45ITALY: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)80
9.3.5SPAIN81
9.3.5.1Rising risk of developing CVD due to age-related disorders to support market growth81
TABLE 46SPAIN: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)81
TABLE 47SPAIN: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)81
TABLE 48SPAIN: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)82
9.3.6REST OF EUROPE82
TABLE 49REST OF EUROPE: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)82
TABLE 50REST OF EUROPE: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)83
TABLE 51REST OF EUROPE: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)83
9.4ASIA PACIFIC83
FIGURE 22ASIA PACIFIC: VASCULAR PATCHES MARKET SNAPSHOT (2021)84
TABLE 52ASIA PACIFIC: VASCULAR PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)85
TABLE 53ASIA PACIFIC: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)85
TABLE 54ASIA PACIFIC: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)85
TABLE 55ASIA PACIFIC: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)86
9.4.1CHINA86
9.4.1.1Rising prevalence of chronic heart diseases to drive market86
TABLE 56CHINA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)86
TABLE 57CHINA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)87
TABLE 58CHINA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)87
9.4.2JAPAN87
9.4.2.1Rising public healthcare spending to drive demand for vascular patches87
TABLE 59JAPAN: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)88
TABLE 60JAPAN: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)88
TABLE 61JAPAN: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)88
9.4.3INDIA89
9.4.3.1Rising incidence of CVD to drive market89
TABLE 62INDIA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)89
TABLE 63INDIA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)89
TABLE 64INDIA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)90
9.4.4REST OF ASIA PACIFIC90
TABLE 65REST OF ASIA PACIFIC: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)91
TABLE 66REST OF ASIA PACIFIC: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)91
TABLE 67REST OF ASIA PACIFIC: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)91
9.5REST OF THE WORLD92
TABLE 68REST OF THE WORLD: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)92
TABLE 69REST OF THE WORLD: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)93
TABLE 70REST OF THE WORLD: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)93
10COMPETITIVE LANDSCAPE94
10.1OVERVIEW94
10.2STRATEGIES ADOPTED BY KEY PLAYERS94
TABLE 71OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS94
10.3REVENUE SHARE ANALYSIS95
FIGURE 23VASCULAR PATCHES MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS96
10.4MARKET SHARE ANALYSIS96
TABLE 72VASCULAR PATCHES MARKET: DEGREE OF COMPETITION96
FIGURE 24VASCULAR PATCHES MARKET SHARE ANALYSIS, 202197
10.5COMPANY EVALUATION QUADRANT98
10.5.1STARS98
10.5.2EMERGING LEADERS98
10.5.3PERVASIVE PLAYERS98
10.5.4PARTICIPANTS98
FIGURE 25VASCULAR PATCHES MARKET: COMPANY EVALUATION QUADRANT (2021)99
10.6COMPANY FOOTPRINT ANALYSIS99
TABLE 73 COMPANY FOOTPRINT99
TABLE 74COMPANY MATERIAL FOOTPRINT100
TABLE 75COMPANY REGIONAL FOOTPRINT101
10.7COMPETITIVE SCENARIO102
10.7.1DEALS102
TABLE 76VASCULAR PATCHES MARKET: DEALS, 2019–2022102
10.7.2OTHER DEVELOPMENTS102
TABLE 77VASCULAR PATCHES MARKET: OTHER DEVELOPMENTS, 2019–2022102
11COMPANY PROFILES103
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1KEY PLAYERS103
11.1.1BAXTER INTERNATIONAL, INC.103
TABLE 78BAXTER INTERNATIONAL, INC: COMPANY OVERVIEW103
FIGURE 26BAXTER INTERNATIONAL, INC: COMPANY SNAPSHOT (2021)104
11.1.2LEMAITRE VASCULAR, INC.106
TABLE 79LEMAITRE VASCULAR, INC: COMPANY OVERVIEW106
FIGURE 27LEMAITRE VASCULAR, INC: COMPANY SNAPSHOT (2021)106
11.1.3W. L. GORE & ASSOCIATES, INC.108
TABLE 80W. L. GORE & ASSOCIATES: COMPANY OVERVIEW108
11.1.4GETINGE AB110
TABLE 81GETINGE AB: COMPANY OVERVIEW110
FIGURE 28GETINGE AB: COMPANY SNAPSHOT (2021)110
TABLE 82EXCHANGE RATES UTILIZED FOR CONVERSION OF SEK TO USD111
11.1.5B. BRAUN112
TABLE 83B. BRAUN: COMPANY OVERVIEW112
FIGURE 29B. BRAUN: COMPANY SNAPSHOT (2021)113
TABLE 84EXCHANGE RATES UTILIZED FOR CONVERSION OF EUROS TO USD113
11.1.6EDWARDS LIFESCIENCES CORPORATION115
TABLE 85EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW115
FIGURE 30EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2021)116
11.1.7BECTON, DICKINSON AND COMPANY117
TABLE 86BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW117
FIGURE 31BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)118
11.1.8AZIYO BIOLOGICS, INC.119
TABLE 87AZIYO BIOLOGICS, INC: COMPANY OVERVIEW119
FIGURE 32AZIYO BIOLOGICS, INC: COMPANY SNAPSHOT (2021)119
11.1.9TERUMO CORPORATION121
TABLE 88TERUMO CORPORATION: COMPANY OVERVIEW121
FIGURE 33TERUMO CORPORATION: COMPANY SNAPSHOT (2022)122
TABLE 89EXCHANGE RATES UTILIZED FOR CONVERSION OF YEN TO USD122
11.1.10ARTIVION, INC.124
TABLE 90ARTIVION, INC.: COMPANY OVERVIEW124
FIGURE 34ARTIVION, INC: COMPANY SNAPSHOT (2021)124
11.1.11LABCOR LABORATÓRIOS LTDA.126
TABLE 91LABCOR LABORATÓRIOS LTDA.: COMPANY OVERVIEW126
11.2OTHER PLAYERS127
11.2.1VUP MEDICAL127
TABLE 92VUP MEDICAL: COMPANY OVERVIEW127
11.2.2AEGIS LIFESCIENCES127
TABLE 93AEGIS LIFESCIENCES: COMPANY OVERVIEW127
11.2.3SYNKROMAX BIOTECH PVT. LTD.128
TABLE 94SYNKROMAX BIOTECH PVT. LTD: COMPANY OVERVIEW128
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12APPENDIX129
12.1INDUSTRY EXPERT INSIGHTS129
12.2DISCUSSION GUIDE130
12.3KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL133
12.4CUSTOMIZATION OPTIONS135
12.5RELATED REPORTS135
12.6AUTHOR DETAILS136

Report Title: Vascular Patches Market by Material (Biologic, Synthetic), Application (Open Repair of Abdominal Aortic Aneurysm, Congenital Heart Disease, Carotid Endarterectomy), End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW